Europe (WHO region) vs Kazakhstan: Hypertension treatment coverage among adults aged 30-79 with
Europe (WHO region)
52.9%
in 2019
Kazakhstan
70.5%
in 2019
Europe (WHO region) rank
3rd
Kazakhstan rank
4th
Hypertension treatment coverage among adults aged 30-79 with over time
- Europe (WHO region)
- Kazakhstan
How they compare
Kazakhstan currently reports 70.5% against 52.9% in Europe (WHO region), a difference of 17.6%.
That makes Kazakhstan's figure about 1.3 times Europe (WHO region)'s.
Across all 30 years both countries report, Kazakhstan has been ahead every year.
Europe (WHO region) ranks 3rd and Kazakhstan ranks 4th of 11 groups.
Kazakhstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Europe (WHO region) | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 31.2% | 43.9% | 12.7% | Kazakhstan |
| 2000s | 43.5% | 56.8% | 13.3% | Kazakhstan |
| 2010s | 51.5% | 67.2% | 15.7% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension treatment coverage among adults aged 30-79 with, Europe (WHO region) or Kazakhstan?
- Kazakhstan, at 70.5% against 52.9% in Europe (WHO region) as of 2019.
- What is the difference in hypertension treatment coverage among adults aged 30-79 with between Europe (WHO region) and Kazakhstan?
- 17.6%, with Kazakhstan ahead.
- How many years of comparable data are there for Europe (WHO region) and Kazakhstan?
- 30 years are reported by both, from 1990 to 2019.
- How do Europe (WHO region) and Kazakhstan rank globally for hypertension treatment coverage among adults aged 30-79 with?
- Europe (WHO region) ranks 3rd and Kazakhstan ranks 4th of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension treatment coverage among adults aged 30-79 with hypertension, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.